Third Rock Raises $770M To Boost Biotech Portfolio
Boston-based venture capital firm Third Rock Ventures LLC, which has created or invested in more than 50 biotechnology startups, said Thursday that it has raised $770 million in an oversubscribed fifth round of...To view the full article, register now.
Already a subscriber? Click here to view full article